David Roodman, M.D., Ph.D.'s Archive

Dr. David Roodman is director of the Multiple Myeloma Center at the University of Pittsburgh Cancer Institute and director of the Center for Bone Biology at the University of Pittsburgh Medical Center.  His research focuses on multiple myeloma and Paget’s disease. Dr. Roodman writes a quarterly column for The Myeloma Beacon.

David Roodman, M.D., Ph.D. has written 1 article(s) .

[ by | Sep 23, 2011 3:46 pm | 4 Comments ]
Recent Advances In The Treatment Of Myeloma Bone Disease

Multiple myeloma is the most frequent cancer to involve the skeleton, with up to 80 percent of patients having bone disease. Although fewer patients appear to have bone involvement more recently, it is still a major source of both complications and death among patients with myeloma.

Bone disease is so severe in myeloma because the normal bone remodeling process is disrupted. In normal individuals, damaged bone is removed by bone-destroying cells, the osteoclasts, and then bone is replaced by bone-forming …

Tags: , , , , , , , , , ,
Read the full story »